These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 15256476)

  • 1. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.
    Bau DT; Fu YP; Chen ST; Cheng TC; Yu JC; Wu PE; Shen CY
    Cancer Res; 2004 Jul; 64(14):5013-9. PubMed ID: 15256476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA double-strand break repair capacity and risk of breast cancer.
    Bau DT; Mau YC; Ding SL; Wu PE; Shen CY
    Carcinogenesis; 2007 Aug; 28(8):1726-30. PubMed ID: 17494053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
    Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
    Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
    Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
    Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
    Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
    Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
    Wang HC; Chou WC; Shieh SY; Shen CY
    Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of major defects in non-homologous DNA end joining in human breast cancer cell lines.
    Mérel P; Prieur A; Pfeiffer P; Delattre O
    Oncogene; 2002 Aug; 21(36):5654-9. PubMed ID: 12165865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility.
    Ding SL; Yu JC; Chen ST; Hsu GC; Kuo SJ; Lin YH; Wu PE; Shen CY
    Carcinogenesis; 2009 Jan; 30(1):43-9. PubMed ID: 18974064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts.
    Zhong Q; Boyer TG; Chen PL; Lee WH
    Cancer Res; 2002 Jul; 62(14):3966-70. PubMed ID: 12124328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining.
    Baldeyron C; Jacquemin E; Smith J; Jacquemont C; De Oliveira I; Gad S; Feunteun J; Stoppa-Lyonnet D; Papadopoulo D
    Oncogene; 2002 Feb; 21(9):1401-10. PubMed ID: 11857083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.
    Zhuang J; Zhang J; Willers H; Wang H; Chung JH; van Gent DC; Hallahan DE; Powell SN; Xia F
    Cancer Res; 2006 Feb; 66(3):1401-8. PubMed ID: 16452195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
    Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
    Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
    Zhang J; Powell SN
    Mol Cancer Res; 2005 Oct; 3(10):531-9. PubMed ID: 16254187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.
    Han J; Hankinson SE; Zhang SM; De Vivo I; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):520-4. PubMed ID: 15066914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of BRCA1 in non-homologous end-joining.
    Bau DT; Mau YC; Shen CY
    Cancer Lett; 2006 Aug; 240(1):1-8. PubMed ID: 16171943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
    Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
    Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.
    Jakubowska A; Narod SA; Goldgar DE; Mierzejewski M; Masojć B; Nej K; Huzarska J; Byrski T; Górski B; Lubiński J
    Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):457-9. PubMed ID: 12750242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland.
    Jorgensen TJ; Visvanathan K; Ruczinski I; Thuita L; Hoffman S; Helzlsouer KJ
    Breast Cancer Res Treat; 2007 Jan; 101(1):65-71. PubMed ID: 16823510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.